5th gen glp 1 agonist Market Overview: GLP-1 Agonists and the Obesity Market | Blog Mapping the effectiveness and risks

The studys limitations include its reliance on a US sample and a retrospective design, which may introduce bias and limit generalizability

wrote major parts of the manuscript

Liraglutide is a synthetic version of GLP-1, tailored to be long-lasting in the body, and works by mimicking the actions of GLP-1 in the body

In contrast, the present study found no association in the intention-to-treat analysis but found dementia risk reduction with GLP1 receptor agonists in as-treated analyses

Despite numerous studies, the causes of the obesity epidemic are still not fully understood, and traditional calorie-restricted diets still lack long-term effects (133)